These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 7980632

  • 1. Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
    Varani K, Borea PA, Guerra L, Dionisotti S, Zocchi C, Ongini E.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1658-61. PubMed ID: 7980632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.
    Br J Pharmacol; 1996 Apr 18; 117(7):1381-6. PubMed ID: 8730729
    [Abstract] [Full Text] [Related]

  • 5. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun 18; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 6. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP, Curtis AR, Kendall DA, Hill SJ.
    Br J Pharmacol; 1994 Dec 18; 113(4):1501-7. PubMed ID: 7889308
    [Abstract] [Full Text] [Related]

  • 7. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA, Johansson B, Constantino MD, Sebastião AM, Fredholm BB.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb 18; 353(3):261-71. PubMed ID: 8692280
    [Abstract] [Full Text] [Related]

  • 8. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA, Constantino MD, Ribeiro JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 18; 359(4):295-302. PubMed ID: 10344528
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR, Buffoni RS, Giusti L, Lucacchini A.
    J Recept Signal Transduct Res; 1995 Apr 18; 15(7-8):905-29. PubMed ID: 8673723
    [Abstract] [Full Text] [Related]

  • 10. Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites.
    Wan W, Sutherland GR, Geiger JD.
    J Neurochem; 1990 Nov 18; 55(5):1763-71. PubMed ID: 2213023
    [Abstract] [Full Text] [Related]

  • 11. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP, Richardson PJ.
    Br J Pharmacol; 1995 Jan 18; 114(2):537-43. PubMed ID: 7881753
    [Abstract] [Full Text] [Related]

  • 12. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.
    Br J Pharmacol; 1997 Nov 18; 122(6):1202-8. PubMed ID: 9401787
    [Abstract] [Full Text] [Related]

  • 13. A1- and A2-purinoceptors in the guinea-pig uterus.
    Haynes JM, Pennefather JN.
    Clin Exp Pharmacol Physiol; 1993 Oct 18; 20(10):609-17. PubMed ID: 8261655
    [Abstract] [Full Text] [Related]

  • 14. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H, Mori A, Ichimura M, Shindou T, Yanagawa K, Shimada J, Kase H.
    Mol Pharmacol; 1994 Nov 18; 46(5):817-22. PubMed ID: 7969067
    [Abstract] [Full Text] [Related]

  • 15. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
    Mazzoni MR, Giusti L, Rossi E, Taddei S, Lucacchini A.
    Biochim Biophys Acta; 1997 Feb 21; 1324(1):159-70. PubMed ID: 9059509
    [Abstract] [Full Text] [Related]

  • 16. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.
    Hüttemann E, Ukena D, Lenschow V, Schwabe U.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar 21; 325(3):226-33. PubMed ID: 6328333
    [Abstract] [Full Text] [Related]

  • 17. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
    Rivkees SA, Lasbury ME, Barbhaiya H.
    J Biol Chem; 1995 Sep 01; 270(35):20485-90. PubMed ID: 7657625
    [Abstract] [Full Text] [Related]

  • 18. Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity.
    Dionisotti S, Zocchi C, Varani K, Borea PA, Ongini E.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec 01; 346(6):673-6. PubMed ID: 1484565
    [Abstract] [Full Text] [Related]

  • 19. Study of adenosine A2 receptors in membrane preparations from optic tectum of chicks.
    Tasca CI, Cardoso LF, Vendite D, Souza DO.
    Neurochem Res; 1999 Aug 01; 24(8):1067-74. PubMed ID: 10478947
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
    Jarvis MF, Williams M, Do UH, Sills MA.
    Mol Pharmacol; 1991 Jan 01; 39(1):49-54. PubMed ID: 1987452
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.